Immunonutrition - Supplementary amino acids and fatty acids ameliorate immune deficiency in critically ill patients

被引:31
作者
Grimm H. [1 ]
Kraus A. [2 ]
机构
[1] Department of General and Thoracic Surgery, Klinik Für Allgemeinund Thoraxchirurgie der Justus-Liebig-Universität Gießen), Justus Liebig University, 35385 Giessen
[2] Department of Haematology, Oncology and Immunology, Philipps University, Marburg
关键词
Conditionally essential amino acids; Immune deficiency; Immunonutrition; Polyunsaturated fatty acids;
D O I
10.1007/s004230100241
中图分类号
学科分类号
摘要
Background: Immunonutrition with ω-3 fatty acids and the "conditionally essential" amino acids arginine, glutamine, cysteine, and taurine can enhance the immune response in critically ill patients. This is due to the immunomodulating properties of these nutrients. Immunonutrition is especially important when a patient's immune response is compromised, as is the case post-operatively or after trauma. Immune deficiency is severely aggravated in sepsis and the systemic inflammatory response syndrome (SIRS). The resulting metabolic stress is characterized by glycolysis, lipolysis, and proteolysis, which may escalate to an hypercatabolic response or "autocannabilism." Catabolic metabolism results in insufficiency of both specific and unspecific immunocompetent cells. Conclusions: Immunonutrition should be started early in such patients for an optimal beneficial effect, preferably via the enteral route. It should include medium chain and long chain triglycerides, polyunsaturated ω-3 and ω-6 fatty acids (in the ratio 1:2), olive oil, and conventional amino acid preparations supplemented with the conditionally essential amino acids arginine, glutamine, cysteine, and taurine.
引用
收藏
页码:369 / 376
页数:7
相关论文
共 70 条
[1]
Chandra R., Nutrition an immunology, Liss, New York, (1989)
[2]
Wolfe R.R., Herndon D.N., Jahoor F., Miyoshi H., Wolfe M., Effect of severe burn injury on substrate cycling by glucose and fatty acids, New Engl J Med, 317, (1987)
[3]
Haglund U., Bulkley G.B., Granger D.N., On the pathophysiology of intestinal ischémie injury, Acta Chir Scand, 153, pp. 321-324, (1987)
[4]
Walker W.A., Role of the mucosal barrier in toxin/microbial attachment to the gastrointestinal tract, Ciba Found Symp, 112, pp. 34-47, (1985)
[5]
Deitch E.A., Multiple organ failure, Pathophysiology and Potential Future Therapy. Ann Surg, 216, pp. 117-134, (1992)
[6]
Gwosdow A.R., Msa K., Bode H.H., Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis, Am J Physiol, 258, pp. 65-70, (1990)
[7]
Michie H.R., Manogue K.R., Spriggs D.R., Detection of circulating tumour necrosis factor after endotoxin administration, N Engl J Med, 318, pp. 1481-1486, (1988)
[8]
Spath-Schwalbe E., Born J., Schrezenmeier H., Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man, J Clin Endocrinol Metab, 79, pp. 1212-1214, (1994)
[9]
Lafontan M., Berlan M., Fat cell adrenergic receptors and the control of white and brown fat cell function, J Lipid Res, 34, pp. 1057-1091, (1993)
[10]
Morin C.L., Schlaepfer I.R., Eckel R.H., Tumour necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes, J Clin Invest, 95, pp. 1684-1689, (1995)